Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FR183998 free base is an inhibitor of Na+/Ca2+ Exchanger.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 349.00 | |
5 mg | In stock | $ 690.00 | |
10 mg | In stock | $ 992.00 | |
25 mg | In stock | $ 1,470.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,680.00 |
Description | FR183998 free base is an inhibitor of Na+/Ca2+ Exchanger. |
Targets&IC50 | Na+, H+ exchange (human platelet):3.1 nM , Na+, H+ exchange (rat lymphocytes):0.3 nM , Na+, H+ exchange (rat platelet):6.5 nM |
In vitro | FR183998 free base has potent inhibitory effects on Na+/H+ exchanger in rat lymphocytes, rat platelets, and human platelets with IC50s of 0.3 nM, 6.5 nM, and 3.1 nM, respectively[1]. |
In vivo | Administered intravenously at 1 mg/kg, FR183998 free base diminishes the serum elevation of alanine transaminase, aspartate transaminase, and lactate dehydrogenase caused by hepatic ischemia/reperfusion (I/R), while also preventing hepatic necrosis, apoptosis, and neutrophil infiltration. It inhibits the I/R-triggered activation of NF-κB, downregulates iNOS induction, and curbs nitric oxide production, in addition to reducing the liver's iNOS gene antisense transcript expression in hepatic I/R rats. At dosages of 0.1 and 1.0 mg/kg via intravenous injection, FR183998 free base does not alter hemodynamic parameters, mean blood pressure, or heart rate in conscious rats. Both pre- and post-treatment with FR183998 free base, in doses ranging from 0.01 to 0.10 mg/kg intravenously, dose-dependently mitigates reperfusion-induced ventricular fibrillation and mortality in anesthetized rats, showing ED50 values against ventricular fibrillation of 0.015 mg/kg and 0.070 mg/kg, respectively. Moreover, it significantly reduces myocardial infarct sizes and suppresses arrhythmias in anesthetized rats. |
Molecular Weight | 428.34 |
Formula | C17H19Cl2N5O2S |
CAS No. | 239440-20-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL (466.9 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FR183998 free base 239440-20-1 Membrane transporter/Ion channel Na+/Ca2+ Exchanger FR-183998 FR 183998 FR-183998 free base FR183998 inhibitor inhibit